Infectious Diseases in Critical Care Medicine

spontaneous bacterial empyema includeE. coli,K. pneumoniae, and streptococci, including
Enterococcusspecies, andS. bovis. A diagnostic thoracentesis is recommended in patients with
cirrhosis who develop pleural effusions and signs and symptoms of infection (77).

REFERENCES

1. Navasa M, Rimola A, Rode ́s J. Bacterial infections in liver disease. Seminars Liver Dis 1997; 17:323–333.


2. Navasa M, Rode ́s J. Bacterial infections in cirrhosis. Liver Int 2004; 24:277–280.


3. Johnson DH, Cunha BA. Infections in cirrhosis. Infect Dis Clin No Amer 2001; 15:363–371.


4. Vilstrup H. Cirrhosis and bacterial infections. Rom J Gastroenterol 2003; 12:297–302.


5. Sørensen HT, Thulstrup AM, Mellemkjar L, et al. Long-term survival and cause-specific mortality in
   patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J Clin Epidem 2003; 56:88–93.


6. Descheˆnes M, Villeneuve J. Risk factors for the development of bacterial infections in hospitalized
   patients with cirrhosis. Am J Gastroenterol 1999; 94:2193–2197.


7. Soares-Weiser K, Brezis M, Tur-Kaspa R, et al. Antibiotic prophylaxis of bacterial infections in
   cirrhotic inpatients: a meta-analysis of randomized controlled clinical trials. Scand J Gastroenterol
   2003; 38:193–200.


8. Singh N, Yu VL, Wagener MM, et al. Cirrhotic fever in the 1990s: a prospective study with clinical
   implications. Clin Infect Dis 1997; 24:1135–1138.


9. Rimola A, Soto R, Bory F, et al. Reticuloendothelial system phagocytic activity in cirrhosis and its
   relation to bacterial infections and prognosis. Hepatology 1984; 4:53–58.


10. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing, and
    metabolic activity in alcoholic cirrhosis and heptatitis. Hepatology 1986; 6:252–262.


11. Gentry MJ, Snitily MU, Preheim LC. Phagocytosis ofStreptococcus pneumoniaemeasured in vitro and
    in vivo in a rat model of carbon tetrachloride-induced liver cirrhosis. J Infect Dis 1995; 171:350–355.


12. Gentry MJ, Snitily MU, Preheim LC. Decreased uptake and killing ofStreptococcus pneumoniaewithin
    the lungs of cirrhotic rats. Immunol Infect Dis 1996; 6:43–47.


13. Fierer J, Finley F. Serum bactericidal activity againstEscherichia coliin patients with cirrhosis of the
    liver. J Clin Invest 1979; 63:912–921.


14. Lister PD, Mellencamp MA, Preheim LC. Serum-sensitiveEscherichia colimultiply in cirrhotic serum.
    J Lab Clin Med 1992; 120:633–638.


15. Mellencamp MA, Preheim LC. Pneumococcol pneumonia in a rat model of cirrhosis: effects of
    cirrhosis on pulmonary defense mechanisms againstStreptococcus pneumoniae. J Infect Dis 1991;
    163:102–108.


16. Homann C, Varming K, Hogasen K, et al. Acquired C3 deficiency in patients with alcoholic cirrhosis
    predisposes to infection and increased mortality. Gut 1997; 40:544–549.


17. Alcantara RB, Preheim LC, Gentry MJ. The role of pneumolysin’s complement-activating activity
    during pnuemococcal bacteremia in cirrhotic rats. Infect Immun 1999; 67:2862–2866.


18. Baudouin B, Roucloux I, Crusiaux A, et al. Tumor necrosis factoraand interleukin 6 plasma levels in
    infected cirrhotic patients. Gastroenterol 1993; 104:1492–1497.


19. Preheim LC, Mellencamp MA, Snitily MU, et al. Effect of cirrhosis on the production and efficacy of
    pneumococcal capsular antibody in a rat model. Am Rev Respir Dis 1992; 146:1054–1058.


20. Preheim LC, Snitily MU, Gentry MJ. Effects of granulocyte colony-stimulating factor in cirrhotic rats
    with pneumococcal pneumonia. J Infect Dis 1996;174:225–228.


21. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol
    1993; 18:353–358.


22. Yoshida H, Hamada T, Inuzuka S, et al. Bacterial infections in cirrhosis, with and without
    hepatocellular carcinoma. Am J Gastroenterol 1993; 88: 2067–2071.


23. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: a
    multicentre prospective study. Digest Liver Dis 2001; 33:41–48.


24. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal
    varices. Br J Surg 1973; 60:646–649.


25. Rimola A, Navasa M, Arroyo V. Experience with cefotaxime in the treatment of spontaneous bacterial
    peritonitis in cirrhosis. Diagn Microbiol Infect Dis 1995; 22:141–145.


26. Runyon BA, McHutchison JG, Antillon MR, et al. Short-course versus long-course antibiotic treatment
    of spontaneous bacterial peritonitis. Gastroenterol 1991; 100:1737–1742.


27. Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial
    peritonitis. Gastroenterol 1986; 91:1343–1346.


28. Andreu M, Sola R, Sitges-Serra A, et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic
    patients with ascites. Gastroenterol 1993; 104:1133–1138.


29. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous
    bacterial peritonitis: a consensus document. J Hepatol 2000; 32:142–153.

Infections in Cirrhosis in Critical Care 347